体外受精(IVF)の世界市場分析:手順別(細胞内精子注入(ICSI)、凍結胚交換(FER)、着床前遺伝診断(PGD))、サイクルタイプ別(フレッシュ・ドナー、フローズン・ドナー、フレッシュ・ノン・ドナー、フローズン・ノン・ドナー)、機器別(IVDディスポーザブルデバイス、培養培地、資本設備)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】In-Vitro Fertilization (IVF) Market Analysis by Procedures (Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Pre-implantation Genetic Diagnosis (PGD)), By Types of Cycles (Fresh Donor, Frozen Donor, Fresh Non-donor, Frozen Non-donor), By Instruments (IVD Disposable Devices, Culture Media, Capital Equipment), And Segment Forecasts to 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. In-Vitro Fertilization (IVF) Market – Industry Summary and Key Buying Criteria, 2012 – 2022
Chapter 3. In-Vitro Fertilization (IVF)Industry Outlook
3.1. In-Vitro Fertilization (IVF) Market Segmentation
3.2. In-Vitro Fertilization (IVF) Market Size and Growth Prospects
3.3. In-Vitro Fertilization (IVF) Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Key Opportunities Prioritized
3.5. Industry analysis – Porter’s
3.6. In-Vitro Fertilization (IVF) Market PESTEL Analysis, 2014
3.7. Competitive landscape
Chapter 4. In-Vitro Fertilization (IVF)Procedures Outlook
4.1. In-Vitro Fertilization (IVF)Market Share by procedures, 2014 & 2022
4.2. Intracytoplasmic Sperm Injection(ICSI) Market Estimates and Forecasts, 2012 – 2022 (USD Million)
4.3. Frozen Embryo Replacement (FER) Market Estimates and Forecasts, 2012 – 2022 (USD Million)
4.4. Pre-implantation Genetic Diagnosis (PGD) Market Estimates and Forecasts, 2012 – 2022 (USD Million)
4.5. Others Market Estimates and Forecasts, 2012 – 2022 (USD Million)
Chapter 5. In-Vitro Fertilization (IVF) Type of Cycles Outlook
5.1. In-Vitro Fertilization (IVF) Market Share by type of cycles, 2014 & 2022
5.2. Fresh Donor Market Estimates and Forecasts, 2012 – 2022 (USD Million)
5.3. Fresh Non-donor Market Estimates And Forecasts, 2012 – 2022 (USD Million)
5.4. Frozen Donor Market Estimates and Forecasts, 2012 – 2022 (USD Million)
5.5. Frozen Non-donor Market Estimates And Forecasts, 2012 – 2022 (USD Million)
Chapter 6. In-Vitro Fertilization (IVF) Instruments Outlook
6.1. In-Vitro Fertilization (IVF) Market Share by instruments, 2014 & 2022
6.2. Culture media Market Estimates and Forecasts, 2012 – 2022 (USD Million)
6.3. Capital equipment Market Estimates and Forecasts, 2012 – 2022 (USD Million)
6.4. IVF disposable devices Market Estimates and Forecasts, 2012 – 2022 (USD Million)
Chapter 7. In-Vitro Fertilization (IVF)Regional Outlook
7.1. North America
7.1.1. North America In-Vitro Fertilization (IVF) Market Estimates And Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.1.1.1. U.S. Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.1.2. Canada Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.2. North America In-Vitro Fertilization (IVF) Market Estimates And Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.1.2.1. U.S Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.2.2. Canada Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.3. North America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.1.3.1. U.S. Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.3.2. Canada Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2. Europe
7.2.1. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.2.1.1. UK Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.1.2. France Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.1.3. Germany Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.2. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.2.2.1. UK Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.2.2. France Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.2.3. Germany Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.3. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.2.3.1. UK Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.3.2. France Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.3.3. Germany Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3. Asia Pacific
7.3.1. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.3.1.1. India Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.1.2. China Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.1.3. Japan Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.2. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.3.2.1. India Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.2.2. China Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.2.3. Japan Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.3. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.3.3.1. India Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.3.2. China Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.3.3. Japan Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.4. Latin America
7.4.1. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.4.1.1. Mexico market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.1.2. Brazil market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.2. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.4.2.1. Mexico market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.2.2. Brazil market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.3. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.4.3.1. Mexico market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.3.2. Brazil market estimates and forecasts, 2012 – 2022 (USD Million)
7.5. MEA
7.5.1. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.5.1.1. South Africa Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.5.2. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.5.2.1. South Africa Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.5.3. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.5.3.1. South Africa Market Estimates and Forecasts, 2012 – 2022 (USD Million)
Chapter 8. Competitive Landscape
9.1 OvaScience
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Vitrolife AB
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic initiatives
9.3 EMD Serono, Inc.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Products Benchmarking
9.3.4 Strategic initiatives
9.4 Irvine Scientific
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic initiatives
9.5 CooperSurgical, Inc.
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Products Benchmarking
9.5.4 Strategic initiatives
9.6 Cook Medical, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic initiatives
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Products Benchmarking
9.7.4 Strategic initiatives
9.8 Genea Biomedx
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Progyny,Inc.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Boston IVF
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:体外受精(IVF)の世界市場分析:手順別(細胞内精子注入(ICSI)、凍結胚交換(FER)、着床前遺伝診断(PGD))、サイクルタイプ別(フレッシュ・ドナー、フローズン・ドナー、フレッシュ・ノン・ドナー、フローズン・ノン・ドナー)、機器別(IVDディスポーザブルデバイス、培養培地、資本設備)、セグメント予測
■ 英文:In-Vitro Fertilization (IVF) Market Analysis by Procedures (Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Pre-implantation Genetic Diagnosis (PGD)), By Types of Cycles (Fresh Donor, Frozen Donor, Fresh Non-donor, Frozen Non-donor), By Instruments (IVD Disposable Devices, Culture Media, Capital Equipment), And Segment Forecasts to 2022
■ 発行日:2016年5月3日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707455
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。